

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine deamination (GO:0009972) | 8.65709466 |
| 2 | cytidine metabolic process (GO:0046087) | 8.65709466 |
| 3 | cytidine catabolic process (GO:0006216) | 8.65709466 |
| 4 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 8.01917061 |
| 5 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 7.60155987 |
| 6 | cellular response to interleukin-15 (GO:0071350) | 6.97668818 |
| 7 | DNA deamination (GO:0045006) | 6.51641539 |
| 8 | response to interleukin-15 (GO:0070672) | 6.45514825 |
| 9 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 6.21458376 |
| 10 | adaptation of signaling pathway (GO:0023058) | 6.17036295 |
| 11 | eosinophil chemotaxis (GO:0048245) | 5.80173303 |
| 12 | regulation of T cell chemotaxis (GO:0010819) | 5.72307536 |
| 13 | positive regulation of T cell chemotaxis (GO:0010820) | 5.72307536 |
| 14 | cell wall macromolecule catabolic process (GO:0016998) | 5.42045740 |
| 15 | regulation of activation of Janus kinase activity (GO:0010533) | 5.39714308 |
| 16 | negative regulation by host of viral transcription (GO:0043922) | 5.36032781 |
| 17 | regulation of lymphocyte chemotaxis (GO:1901623) | 5.29220164 |
| 18 | eosinophil migration (GO:0072677) | 5.22232621 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.01712243 |
| 20 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.98635239 |
| 21 | regulation of regulatory T cell differentiation (GO:0045589) | 4.98198420 |
| 22 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.89997091 |
| 23 | regulation of chronic inflammatory response (GO:0002676) | 4.85096947 |
| 24 | monocyte chemotaxis (GO:0002548) | 4.70300065 |
| 25 | cell wall macromolecule metabolic process (GO:0044036) | 4.51387835 |
| 26 | negative regulation of viral genome replication (GO:0045071) | 4.48058521 |
| 27 | positive thymic T cell selection (GO:0045059) | 4.46303534 |
| 28 | interferon-gamma production (GO:0032609) | 4.43752776 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 4.42065911 |
| 30 | granulocyte activation (GO:0036230) | 4.32782831 |
| 31 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.27178617 |
| 32 | positive regulation of lymphocyte migration (GO:2000403) | 4.26100074 |
| 33 | macrophage chemotaxis (GO:0048246) | 4.22815125 |
| 34 | negative T cell selection (GO:0043383) | 4.10231679 |
| 35 | regulation of mononuclear cell migration (GO:0071675) | 4.06238726 |
| 36 | positive T cell selection (GO:0043368) | 4.02499842 |
| 37 | regulation of macrophage chemotaxis (GO:0010758) | 4.02165930 |
| 38 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.93246554 |
| 39 | regulation of T cell tolerance induction (GO:0002664) | 3.91579001 |
| 40 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.86641755 |
| 41 | T cell migration (GO:0072678) | 3.83264511 |
| 42 | negative regulation of T cell apoptotic process (GO:0070233) | 3.79529631 |
| 43 | chemokine-mediated signaling pathway (GO:0070098) | 3.77851449 |
| 44 | positive regulation of tolerance induction (GO:0002645) | 3.76358173 |
| 45 | lymphocyte chemotaxis (GO:0048247) | 3.75452011 |
| 46 | positive regulation of T cell migration (GO:2000406) | 3.73429899 |
| 47 | neutrophil activation (GO:0042119) | 3.72920323 |
| 48 | dendritic cell chemotaxis (GO:0002407) | 3.72839977 |
| 49 | protein neddylation (GO:0045116) | 3.72660314 |
| 50 | negative thymic T cell selection (GO:0045060) | 3.71057388 |
| 51 | lymph node development (GO:0048535) | 3.70618285 |
| 52 | natural killer cell activation (GO:0030101) | 3.60265931 |
| 53 | negative regulation of B cell proliferation (GO:0030889) | 3.58447754 |
| 54 | thymic T cell selection (GO:0045061) | 3.54790019 |
| 55 | positive regulation of defense response to virus by host (GO:0002230) | 3.54665397 |
| 56 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.53567120 |
| 57 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.53487740 |
| 58 | * cellular defense response (GO:0006968) | 3.51365104 |
| 59 | regulation of T cell migration (GO:2000404) | 3.50805054 |
| 60 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.50417149 |
| 61 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.49708908 |
| 62 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.49708908 |
| 63 | positive regulation of macrophage differentiation (GO:0045651) | 3.48494882 |
| 64 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.46442037 |
| 65 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.45364260 |
| 66 | positive regulation of translational initiation (GO:0045948) | 3.39734076 |
| 67 | regulation of lymphocyte migration (GO:2000401) | 3.39076362 |
| 68 | T cell costimulation (GO:0031295) | 3.36280041 |
| 69 | regulation of monocyte chemotaxis (GO:0090025) | 3.35820795 |
| 70 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.32653878 |
| 71 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.32620887 |
| 72 | lymphocyte costimulation (GO:0031294) | 3.31684575 |
| 73 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.31454219 |
| 74 | positive regulation of T cell apoptotic process (GO:0070234) | 3.29352708 |
| 75 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.26814116 |
| 76 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.25304050 |
| 77 | regulation of tolerance induction (GO:0002643) | 3.23312523 |
| 78 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.18391649 |
| 79 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.18391649 |
| 80 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.17710570 |
| 81 | regulation of cell killing (GO:0031341) | 3.16507034 |
| 82 | negative regulation of B cell activation (GO:0050869) | 3.13725436 |
| 83 | T cell selection (GO:0045058) | 3.11403246 |
| 84 | positive regulation of cell killing (GO:0031343) | 3.09966451 |
| 85 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.07667289 |
| 86 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.06842658 |
| 87 | negative regulation of cell killing (GO:0031342) | 3.06842658 |
| 88 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.01449712 |
| 89 | leukocyte degranulation (GO:0043299) | 3.00576878 |
| 90 | dendritic cell migration (GO:0036336) | 2.97820314 |
| 91 | positive regulation of interleukin-12 production (GO:0032735) | 2.96063274 |
| 92 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.95978079 |
| 93 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.95244272 |
| 94 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.95062029 |
| 95 | regulation of viral genome replication (GO:0045069) | 2.92824273 |
| 96 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.91923872 |
| 97 | diterpenoid biosynthetic process (GO:0016102) | 2.91565218 |
| 98 | lymphocyte migration (GO:0072676) | 2.91296595 |
| 99 | regulation of interleukin-8 secretion (GO:2000482) | 2.88648188 |
| 100 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.86865080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 7.77780830 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.04857676 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.17259577 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.83579053 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.36092952 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.20988645 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.09559882 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.03821545 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.88570512 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.79555413 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.76402890 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 2.60160758 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.36021680 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.18005608 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16628189 |
| 16 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11686965 |
| 17 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.03988993 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 10.3803289 |
| 19 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.93455944 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.89279438 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.88803028 |
| 22 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.82941492 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 1.73711340 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.67545680 |
| 25 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.64322929 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.63594265 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.56620431 |
| 28 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.54664714 |
| 29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.54143004 |
| 30 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.50478140 |
| 31 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44018802 |
| 32 | GATA3_26560356_Chip-Seq_TH2_Human | 1.42798304 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41133837 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.40397250 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.39970387 |
| 36 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.39149194 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35875002 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.33587834 |
| 39 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.27350851 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22271517 |
| 41 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.18882304 |
| 42 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.17269955 |
| 43 | MAF_26560356_Chip-Seq_TH1_Human | 1.17054381 |
| 44 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16553743 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16218023 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15128781 |
| 47 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.13730730 |
| 48 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11083055 |
| 49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.10447917 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.10225324 |
| 51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08769998 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07044793 |
| 53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.05872746 |
| 54 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04733450 |
| 55 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.04137212 |
| 56 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03704674 |
| 57 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02778442 |
| 58 | P300_27268052_Chip-Seq_Bcells_Human | 1.02324962 |
| 59 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.02017790 |
| 60 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.01381407 |
| 61 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00420205 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96881563 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92823933 |
| 64 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92121320 |
| 65 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.91127424 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90584891 |
| 67 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.88984868 |
| 68 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.88150248 |
| 69 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.85846255 |
| 70 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85625557 |
| 71 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85573819 |
| 72 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.84839511 |
| 73 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84582515 |
| 74 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.83778014 |
| 75 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.83083587 |
| 76 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82875654 |
| 77 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.81806327 |
| 78 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.81298910 |
| 79 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.80993086 |
| 80 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.79092189 |
| 81 | AR_20517297_ChIP-Seq_VCAP_Human | 0.76233626 |
| 82 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.75537573 |
| 83 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.75403847 |
| 84 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.74660347 |
| 85 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.74227403 |
| 86 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.73965522 |
| 87 | GATA3_26560356_Chip-Seq_TH1_Human | 0.73068007 |
| 88 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.73042725 |
| 89 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.72379048 |
| 90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.71851428 |
| 91 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.71125600 |
| 92 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.70421807 |
| 93 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.70271391 |
| 94 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.69876149 |
| 95 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.69761647 |
| 96 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.69138543 |
| 97 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.68614173 |
| 98 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.68614173 |
| 99 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.68333366 |
| 100 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.67963618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.78725042 |
| 2 | MP0000569_abnormal_digit_pigmentation | 5.23818988 |
| 3 | MP0006082_CNS_inflammation | 3.96091915 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.63655924 |
| 5 | MP0009785_altered_susceptibility_to | 3.61968154 |
| 6 | MP0003763_abnormal_thymus_physiology | 3.10427738 |
| 7 | MP0003866_abnormal_defecation | 3.00100017 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.91867974 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.89507639 |
| 10 | MP0001800_abnormal_humoral_immune | 2.83355588 |
| 11 | MP0005025_abnormal_response_to | 2.66753532 |
| 12 | MP0001853_heart_inflammation | 2.64122008 |
| 13 | MP0005387_immune_system_phenotype | 2.59757138 |
| 14 | MP0001790_abnormal_immune_system | 2.59757138 |
| 15 | MP0002723_abnormal_immune_serum | 2.57618205 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.56917438 |
| 17 | MP0001819_abnormal_immune_cell | 2.53426622 |
| 18 | MP0000685_abnormal_immune_system | 2.32185390 |
| 19 | MP0003436_decreased_susceptibility_to | 2.31485558 |
| 20 | MP0001873_stomach_inflammation | 2.24166588 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.24129519 |
| 22 | MP0005174_abnormal_tail_pigmentation | 2.14818336 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.11479250 |
| 24 | MP0002398_abnormal_bone_marrow | 2.10658883 |
| 25 | MP0002405_respiratory_system_inflammati | 2.06047270 |
| 26 | MP0004510_myositis | 2.01063579 |
| 27 | MP0000716_abnormal_immune_system | 2.00121230 |
| 28 | MP0005310_abnormal_salivary_gland | 1.94644126 |
| 29 | MP0002419_abnormal_innate_immunity | 1.86746552 |
| 30 | MP0000015_abnormal_ear_pigmentation | 1.75393873 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.72572130 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.68062205 |
| 33 | MP0002877_abnormal_melanocyte_morpholog | 1.67551361 |
| 34 | MP0003045_fibrosis | 1.62636471 |
| 35 | MP0002429_abnormal_blood_cell | 1.58967300 |
| 36 | MP0004947_skin_inflammation | 1.54244420 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.49775035 |
| 38 | MP0002722_abnormal_immune_system | 1.49025976 |
| 39 | MP0002234_abnormal_pharynx_morphology | 1.48984160 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.48860104 |
| 41 | MP0003448_altered_tumor_morphology | 1.40202649 |
| 42 | MP0009765_abnormal_xenobiotic_induced | 1.37414507 |
| 43 | MP0002933_joint_inflammation | 1.33849006 |
| 44 | MP0003724_increased_susceptibility_to | 1.31414497 |
| 45 | MP0005075_abnormal_melanosome_morpholog | 1.30075131 |
| 46 | MP0002095_abnormal_skin_pigmentation | 1.28501088 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.28289879 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.25667211 |
| 49 | MP0003786_premature_aging | 1.16212809 |
| 50 | MP0000858_altered_metastatic_potential | 1.16147542 |
| 51 | MP0010307_abnormal_tumor_latency | 1.13892280 |
| 52 | MP0002006_tumorigenesis | 1.10108494 |
| 53 | MP0009763_increased_sensitivity_to | 1.08750814 |
| 54 | MP0006054_spinal_hemorrhage | 1.07750200 |
| 55 | MP0008469_abnormal_protein_level | 1.07710386 |
| 56 | MP0002132_abnormal_respiratory_system | 1.05392150 |
| 57 | MP0004381_abnormal_hair_follicle | 1.05024523 |
| 58 | MP0005083_abnormal_biliary_tract | 1.00573067 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.00331879 |
| 60 | MP0002693_abnormal_pancreas_physiology | 0.98910383 |
| 61 | MP0008789_abnormal_olfactory_epithelium | 0.95831995 |
| 62 | MP0004147_increased_porphyrin_level | 0.95260946 |
| 63 | MP0002332_abnormal_exercise_endurance | 0.92918767 |
| 64 | MP0004130_abnormal_muscle_cell | 0.91810694 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 0.87535101 |
| 66 | MP0001533_abnormal_skeleton_physiology | 0.85577513 |
| 67 | MP0009764_decreased_sensitivity_to | 0.84621885 |
| 68 | MP0005253_abnormal_eye_physiology | 0.78985245 |
| 69 | MP0002168_other_aberrant_phenotype | 0.78613730 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 0.78281478 |
| 71 | MP0002998_abnormal_bone_remodeling | 0.78002850 |
| 72 | MP0002876_abnormal_thyroid_physiology | 0.77064917 |
| 73 | MP0000920_abnormal_myelination | 0.76981864 |
| 74 | MP0001324_abnormal_eye_pigmentation | 0.75750546 |
| 75 | MP0002102_abnormal_ear_morphology | 0.74718861 |
| 76 | MP0005551_abnormal_eye_electrophysiolog | 0.73931286 |
| 77 | MP0000371_diluted_coat_color | 0.71797966 |
| 78 | MP0002136_abnormal_kidney_physiology | 0.69986187 |
| 79 | MP0002019_abnormal_tumor_incidence | 0.69107447 |
| 80 | MP0003950_abnormal_plasma_membrane | 0.66552912 |
| 81 | MP0008260_abnormal_autophagy | 0.59175097 |
| 82 | MP0003806_abnormal_nucleotide_metabolis | 0.56937414 |
| 83 | MP0001919_abnormal_reproductive_system | 0.56924914 |
| 84 | MP0004043_abnormal_pH_regulation | 0.55888212 |
| 85 | MP0000604_amyloidosis | 0.54900995 |
| 86 | MP0001542_abnormal_bone_strength | 0.54848894 |
| 87 | MP0003690_abnormal_glial_cell | 0.54282563 |
| 88 | MP0005499_abnormal_olfactory_system | 0.52365458 |
| 89 | MP0005394_taste/olfaction_phenotype | 0.52365458 |
| 90 | MP0000465_gastrointestinal_hemorrhage | 0.49755541 |
| 91 | MP0001191_abnormal_skin_condition | 0.49681145 |
| 92 | MP0005390_skeleton_phenotype | 0.48819887 |
| 93 | MP0004185_abnormal_adipocyte_glucose | 0.47996974 |
| 94 | MP0003011_delayed_dark_adaptation | 0.45161651 |
| 95 | MP0005360_urolithiasis | 0.43787692 |
| 96 | MP0005058_abnormal_lysosome_morphology | 0.43723313 |
| 97 | MP0001984_abnormal_olfaction | 0.43567194 |
| 98 | MP0005636_abnormal_mineral_homeostasis | 0.42628387 |
| 99 | MP0000343_altered_response_to | 0.42589249 |
| 100 | MP0001661_extended_life_span | 0.42449940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.41687152 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.75199814 |
| 3 | Abnormality of T cells (HP:0002843) | 5.23423689 |
| 4 | Stomatitis (HP:0010280) | 5.16348336 |
| 5 | Chronic bronchitis (HP:0004469) | 4.96854044 |
| 6 | Chronic diarrhea (HP:0002028) | 4.90537327 |
| 7 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.74681968 |
| 8 | Joint swelling (HP:0001386) | 4.63410613 |
| 9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.49409901 |
| 10 | IgG deficiency (HP:0004315) | 4.35057993 |
| 11 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.06749323 |
| 12 | Absent/shortened dynein arms (HP:0200106) | 4.06749323 |
| 13 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.89713498 |
| 14 | Bronchitis (HP:0012387) | 3.88706786 |
| 15 | Pustule (HP:0200039) | 3.84924955 |
| 16 | Hypoproteinemia (HP:0003075) | 3.67083094 |
| 17 | Recurrent viral infections (HP:0004429) | 3.64944896 |
| 18 | Progressive inability to walk (HP:0002505) | 3.58430872 |
| 19 | Nasal polyposis (HP:0100582) | 3.52205430 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.52205264 |
| 21 | Lymphopenia (HP:0001888) | 3.47176819 |
| 22 | Abnormality of T cell physiology (HP:0011840) | 3.42609254 |
| 23 | Chronic hepatic failure (HP:0100626) | 3.33283165 |
| 24 | Cutaneous melanoma (HP:0012056) | 3.31350520 |
| 25 | Meningitis (HP:0001287) | 3.26374289 |
| 26 | Pulmonary infiltrates (HP:0002113) | 3.21703255 |
| 27 | Congenital stationary night blindness (HP:0007642) | 3.20195598 |
| 28 | Hypoalbuminemia (HP:0003073) | 3.18913899 |
| 29 | Abnormal albumin level (HP:0012116) | 3.18913899 |
| 30 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.18509853 |
| 31 | Albinism (HP:0001022) | 3.18304481 |
| 32 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.17441519 |
| 33 | Recurrent bronchitis (HP:0002837) | 3.14355546 |
| 34 | Autoimmune hemolytic anemia (HP:0001890) | 3.05425172 |
| 35 | Abnormality of the nasal mucosa (HP:0000433) | 2.99639790 |
| 36 | Ureteral stenosis (HP:0000071) | 2.99129236 |
| 37 | Severe visual impairment (HP:0001141) | 2.97640016 |
| 38 | Optic neuritis (HP:0100653) | 2.92119462 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 2.92119462 |
| 40 | Myositis (HP:0100614) | 2.90975324 |
| 41 | Methylmalonic aciduria (HP:0012120) | 2.90197892 |
| 42 | Encephalitis (HP:0002383) | 2.85858522 |
| 43 | Recurrent sinusitis (HP:0011108) | 2.85134557 |
| 44 | Severe combined immunodeficiency (HP:0004430) | 2.82313196 |
| 45 | Pulmonary fibrosis (HP:0002206) | 2.79637813 |
| 46 | IgA deficiency (HP:0002720) | 2.77507515 |
| 47 | Hemoptysis (HP:0002105) | 2.77073785 |
| 48 | Ureteral obstruction (HP:0006000) | 2.75966213 |
| 49 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.74934373 |
| 50 | Recurrent cutaneous fungal infections (HP:0011370) | 2.74934373 |
| 51 | Recurrent abscess formation (HP:0002722) | 2.71654771 |
| 52 | Abnormality of the prostate (HP:0008775) | 2.68542170 |
| 53 | Orchitis (HP:0100796) | 2.66370239 |
| 54 | Obstructive lung disease (HP:0006536) | 2.64916925 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.64916925 |
| 56 | Abnormal ciliary motility (HP:0012262) | 2.64165488 |
| 57 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.58327240 |
| 58 | Hyperventilation (HP:0002883) | 2.55073583 |
| 59 | Vasculitis (HP:0002633) | 2.52671808 |
| 60 | Gangrene (HP:0100758) | 2.52250879 |
| 61 | Abnormality of the pleura (HP:0002103) | 2.50820844 |
| 62 | Abnormality of macrophages (HP:0004311) | 2.47710437 |
| 63 | Panhypogammaglobulinemia (HP:0003139) | 2.46380577 |
| 64 | Recurrent otitis media (HP:0000403) | 2.46125550 |
| 65 | Recurrent bacterial skin infections (HP:0005406) | 2.44689026 |
| 66 | Bronchiectasis (HP:0002110) | 2.43536057 |
| 67 | Chest pain (HP:0100749) | 2.37747253 |
| 68 | Abnormality of eosinophils (HP:0001879) | 2.33168104 |
| 69 | Autoimmune thrombocytopenia (HP:0001973) | 2.32180096 |
| 70 | Hemiplegia (HP:0002301) | 2.27233084 |
| 71 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.26798578 |
| 72 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.26798578 |
| 73 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.26190919 |
| 74 | Combined immunodeficiency (HP:0005387) | 2.25972393 |
| 75 | Gingivitis (HP:0000230) | 2.24427955 |
| 76 | Pancreatic cysts (HP:0001737) | 2.22833731 |
| 77 | Constricted visual fields (HP:0001133) | 2.20685978 |
| 78 | Hepatosplenomegaly (HP:0001433) | 2.16436862 |
| 79 | Increased IgM level (HP:0003496) | 2.14268539 |
| 80 | Abnormality of the renal collecting system (HP:0004742) | 2.13550140 |
| 81 | Leukocytosis (HP:0001974) | 2.11802600 |
| 82 | Recurrent skin infections (HP:0001581) | 2.11256011 |
| 83 | Cheilitis (HP:0100825) | 2.09852127 |
| 84 | Increased serum ferritin (HP:0003281) | 2.04972711 |
| 85 | IgM deficiency (HP:0002850) | 2.03630901 |
| 86 | Abnormality of midbrain morphology (HP:0002418) | 2.01241381 |
| 87 | Molar tooth sign on MRI (HP:0002419) | 2.01241381 |
| 88 | Pulmonary embolism (HP:0002204) | 2.00964701 |
| 89 | Keratoconjunctivitis sicca (HP:0001097) | 2.00340509 |
| 90 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98944141 |
| 91 | Eosinophilia (HP:0001880) | 1.98365186 |
| 92 | Inability to walk (HP:0002540) | 1.97172968 |
| 93 | Agammaglobulinemia (HP:0004432) | 1.92935776 |
| 94 | Ocular albinism (HP:0001107) | 1.92605471 |
| 95 | Keratoconjunctivitis (HP:0001096) | 1.88694483 |
| 96 | Granulocytopenia (HP:0001913) | 1.86630556 |
| 97 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.85585711 |
| 98 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.85585711 |
| 99 | Hematochezia (HP:0002573) | 1.84858576 |
| 100 | Polyneuropathy (HP:0001271) | 1.84567273 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK7 | 3.21155640 |
| 2 | ITK | 2.67751805 |
| 3 | MOS | 2.47731344 |
| 4 | TGFBR2 | 2.39915525 |
| 5 | ACVR1B | 2.24007672 |
| 6 | DAPK2 | 2.17733606 |
| 7 | MST4 | 2.10664083 |
| 8 | KDR | 2.09264757 |
| 9 | TXK | 11.7474816 |
| 10 | STK10 | 1.83970880 |
| 11 | MAPKAPK3 | 1.83819687 |
| 12 | MAP4K1 | 1.78895921 |
| 13 | FES | 1.70546581 |
| 14 | TAOK3 | 1.58263885 |
| 15 | CSK | 1.51252254 |
| 16 | SYK | 1.48858105 |
| 17 | GRK5 | 1.48476116 |
| 18 | JAK3 | 1.34376807 |
| 19 | IRAK3 | 1.33649715 |
| 20 | PDK1 | 1.25666668 |
| 21 | CDK19 | 1.24531059 |
| 22 | TESK2 | 1.22224041 |
| 23 | NME1 | 1.17698199 |
| 24 | LCK | 1.17297704 |
| 25 | EIF2AK1 | 1.16257295 |
| 26 | BCKDK | 1.15944245 |
| 27 | JAK2 | 1.11325494 |
| 28 | TLK1 | 1.11163688 |
| 29 | DAPK1 | 1.11014740 |
| 30 | TYK2 | 1.09988450 |
| 31 | CSF1R | 1.07939818 |
| 32 | ZAP70 | 1.07826156 |
| 33 | MAP2K6 | 1.03992342 |
| 34 | IKBKE | 1.01225454 |
| 35 | IKBKB | 0.93959713 |
| 36 | GRK6 | 0.90185576 |
| 37 | IRAK4 | 0.89517005 |
| 38 | JAK1 | 0.89198690 |
| 39 | TBK1 | 0.85735948 |
| 40 | OXSR1 | 0.85004436 |
| 41 | FRK | 0.84906588 |
| 42 | MELK | 0.81852918 |
| 43 | KIT | 0.79415261 |
| 44 | PRKCQ | 0.79288380 |
| 45 | IGF1R | 0.79012178 |
| 46 | LYN | 0.76034989 |
| 47 | WNK4 | 0.75477685 |
| 48 | NUAK1 | 0.74963169 |
| 49 | NEK2 | 0.71871593 |
| 50 | FYN | 0.71689525 |
| 51 | ADRBK2 | 0.70359374 |
| 52 | IRAK1 | 0.69835523 |
| 53 | BLK | 0.69334917 |
| 54 | MAP4K2 | 0.69139715 |
| 55 | STK16 | 0.63085604 |
| 56 | CLK1 | 0.62963388 |
| 57 | MAP3K13 | 0.60110239 |
| 58 | RIPK4 | 0.59701182 |
| 59 | STK11 | 0.58475785 |
| 60 | EIF2AK2 | 0.58057686 |
| 61 | PDK2 | 0.55394956 |
| 62 | GRK1 | 0.54313136 |
| 63 | PRKD3 | 0.50086244 |
| 64 | TEC | 0.49723859 |
| 65 | PRKCH | 0.47708580 |
| 66 | MAP2K2 | 0.45328717 |
| 67 | FGR | 0.42401983 |
| 68 | MAPKAPK2 | 0.41286092 |
| 69 | AURKA | 0.40289790 |
| 70 | BTK | 0.39952245 |
| 71 | MAP3K6 | 0.39589170 |
| 72 | PDPK1 | 0.38365876 |
| 73 | SIK2 | 0.37897962 |
| 74 | PIK3CG | 0.34595916 |
| 75 | RPS6KA6 | 0.33849609 |
| 76 | MAP3K11 | 0.33655100 |
| 77 | CAMKK2 | 0.33318705 |
| 78 | CHUK | 0.32869139 |
| 79 | TNK2 | 0.32486873 |
| 80 | ADRBK1 | 0.31856691 |
| 81 | INSR | 0.31131470 |
| 82 | PIK3CA | 0.30105527 |
| 83 | MAP3K14 | 0.29420983 |
| 84 | MAPK13 | 0.26307606 |
| 85 | PRKCZ | 0.25312960 |
| 86 | HCK | 0.23944599 |
| 87 | MUSK | 0.23750312 |
| 88 | ARAF | 0.23099831 |
| 89 | PRKCI | 0.22554580 |
| 90 | LIMK1 | 0.20495943 |
| 91 | MAPK15 | 0.20452401 |
| 92 | RPS6KA5 | 0.20333906 |
| 93 | FGFR1 | 0.19801494 |
| 94 | PIM1 | 0.19563817 |
| 95 | RPS6KA2 | 0.18985562 |
| 96 | RPS6KL1 | 0.17462830 |
| 97 | RPS6KC1 | 0.17462830 |
| 98 | MAP3K9 | 0.17308005 |
| 99 | INSRR | 0.16514629 |
| 100 | CAMKK1 | 0.16459401 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.57416923 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.49225849 |
| 3 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 3.95249806 |
| 4 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.62553974 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.48241631 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 3.00192526 |
| 7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.86170807 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.79349693 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.64867457 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.55977984 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.36924588 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.13868215 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.12739730 |
| 14 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 2.07558175 |
| 15 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.95344784 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.81444654 |
| 17 | Proteasome_Homo sapiens_hsa03050 | 1.57390219 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.55065479 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.52322901 |
| 20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.49987618 |
| 21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49806556 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.45305409 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.39450630 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.38127690 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36892615 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.35092011 |
| 27 | Prion diseases_Homo sapiens_hsa05020 | 1.34858019 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34649166 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.28588162 |
| 30 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.18252167 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.17337737 |
| 32 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.11339130 |
| 33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.09377882 |
| 34 | Malaria_Homo sapiens_hsa05144 | 1.01969316 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01135343 |
| 36 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.00848622 |
| 37 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.98815768 |
| 38 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.97050612 |
| 39 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.95621680 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 0.92942943 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 0.91464410 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 0.89521316 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88698814 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 0.87821375 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86466920 |
| 46 | Phototransduction_Homo sapiens_hsa04744 | 0.86014675 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81898029 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.79618607 |
| 49 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.78505845 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.78487367 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.70174190 |
| 52 | Tuberculosis_Homo sapiens_hsa05152 | 0.63515195 |
| 53 | Peroxisome_Homo sapiens_hsa04146 | 0.61690343 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.61384135 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59933415 |
| 56 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.57754670 |
| 57 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53330427 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52784524 |
| 59 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51340485 |
| 60 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48008117 |
| 61 | Parkinsons disease_Homo sapiens_hsa05012 | 0.46283487 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43547713 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.41417313 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.40578883 |
| 65 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.40273065 |
| 66 | Salivary secretion_Homo sapiens_hsa04970 | 0.38454559 |
| 67 | Renin secretion_Homo sapiens_hsa04924 | 0.37649999 |
| 68 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.36470643 |
| 69 | Alzheimers disease_Homo sapiens_hsa05010 | 0.35419220 |
| 70 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32949581 |
| 71 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32352126 |
| 72 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31113709 |
| 73 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29949425 |
| 74 | RNA polymerase_Homo sapiens_hsa03020 | 0.29724193 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 0.28157358 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28152989 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.27257557 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.27177056 |
| 79 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.26759886 |
| 80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.25297867 |
| 81 | GABAergic synapse_Homo sapiens_hsa04727 | 0.25012152 |
| 82 | Morphine addiction_Homo sapiens_hsa05032 | 0.24734235 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.24718606 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.24337883 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.24042711 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.23932925 |
| 87 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.22872702 |
| 88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.22122144 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.21587423 |
| 90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.21060355 |
| 91 | Huntingtons disease_Homo sapiens_hsa05016 | 0.20946689 |
| 92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.19260457 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.18459966 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.18102562 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.16500624 |
| 96 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.16160971 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.16061944 |
| 98 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15769634 |
| 99 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.14608517 |
| 100 | Olfactory transduction_Homo sapiens_hsa04740 | 0.14279374 |

